House Democrats Take Plan B Battle To Appropriations Bill
This article was originally published in The Tan Sheet
Executive Summary
An amendment intended to support the over-the-counter switch of emergency contraceptive Plan B (levonorgestrel) survived debate on the House floor July 13
You may also be interested in...
Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock
An FDA decision on OTC availability of Barr Labs' Plan B emergency contraceptive is expected by the end of January
FDA Approps Amendment Targets Chief Counsel Troy; Pfizer Ties Challenged
The House FDA appropriations bill cuts $500,000 from the budget of the chief counsel's office in response to actions taken by Chief Counsel Daniel Troy
FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
Sen. Hillary Clinton (D-N.Y.) is calling for a hearing and separate GAO investigation into FDA's decision to deny OTC approval of Barr's Plan B (levenorgestrel) emergency contraceptive